Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Utah Medical Products, Inc. UTMD

Full chart Compare
Set alert

Price alert · UTMD

All alert types
72.23 USD +1.19 (+1.68%)

At closeNov 6, 2026, 4:00 PM EST

72.23 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

70.58 Day range 72.73
53.80 52-week range 76.66
YTD
+29.07%
1 year
+24.79%

Financial health

Altman Z-Score

27.47 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

A4 / 5 overall

  • DCF 4
  • Return on Equity 3
  • Return on Assets 5
  • Debt / Equity 5
  • P/E 2
  • P/B 3

Valuation

P/E 16.1×
FY 2016: 22.6×FY 2017: 35.5×FY 2018: 16.7×FY 2019: 27.2×FY 2020: 28.6×FY 2021: 24.7×FY 2022: 22.2×FY 2023: 18.4×FY 2024: 15.5×FY 2025: 16.1×
FY 2016 5y median 18.4× FY 2025
P/S 4.7×
FY 2016: 6.9×FY 2017: 7.3×FY 2018: 7.4×FY 2019: 8.6×FY 2020: 7.3×FY 2021: 7.4×FY 2022: 7.0×FY 2023: 6.1×FY 2024: 5.3×FY 2025: 4.7×
FY 2016 5y median 6.1× FY 2025
P/B 1.5×
FY 2016: 3.9×FY 2017: 3.9×FY 2018: 3.5×FY 2019: 4.0×FY 2020: 3.0×FY 2021: 3.4×FY 2022: 3.2×FY 2023: 2.4×FY 2024: 1.8×FY 2025: 1.5×
FY 2016 5y median 2.4× FY 2025
P/FCF 12.7×
FY 2016: 24.3×FY 2017: 19.8×FY 2018: 18.9×FY 2019: -89.5×FY 2020: 16.0×FY 2021: 17.7×FY 2022: 18.0×FY 2023: 14.2×FY 2024: 14.8×FY 2025: 12.7×
FY 2016 5y median 14.8× FY 2025
EV/EBITDA 5.6×
FY 2016: 13.0×FY 2017: 12.1×FY 2018: 12.0×FY 2019: 14.6×FY 2020: 12.3×FY 2021: 11.5×FY 2022: 10.5×FY 2023: 8.6×FY 2024: 6.8×FY 2025: 5.6×
FY 2016 5y median 8.6× FY 2025
EV/Sales 2.5×
FY 2016: 6.3×FY 2017: 6.3×FY 2018: 6.2×FY 2019: 7.7×FY 2020: 6.1×FY 2021: 6.2×FY 2022: 5.6×FY 2023: 4.3×FY 2024: 3.2×FY 2025: 2.5×
FY 2016 5y median 4.3× FY 2025
FCF Yield 7.9%
FY 2016: 4.1%FY 2017: 5.1%FY 2018: 5.3%FY 2019: -1.1%FY 2020: 6.3%FY 2021: 5.7%FY 2022: 5.6%FY 2023: 7.1%FY 2024: 6.8%FY 2025: 7.9%
FY 2016 5y median 6.8% FY 2025

Profitability

Gross Margin 57.1%
FY 2016: 60.3%FY 2017: 63.7%FY 2018: 62.6%FY 2019: 62.8%FY 2020: 60.6%FY 2021: 63.0%FY 2022: 61.6%FY 2023: 59.8%FY 2024: 59.0%FY 2025: 57.1%
FY 2016 5y median 59.8% FY 2025
Operating Margin 29.6%
FY 2016: 41.2%FY 2017: 45.9%FY 2018: 44.5%FY 2019: 37.6%FY 2020: 32.5%FY 2021: 38.5%FY 2022: 37.9%FY 2023: 33.4%FY 2024: 33.2%FY 2025: 29.6%
FY 2016 5y median 33.4% FY 2025
Net Margin 29.3%
FY 2016: 30.9%FY 2017: 20.5%FY 2018: 44.2%FY 2019: 31.4%FY 2020: 25.6%FY 2021: 30.1%FY 2022: 31.5%FY 2023: 33.1%FY 2024: 33.9%FY 2025: 29.3%
FY 2016 5y median 31.5% FY 2025
ROE 9.5%
FY 2016: 17.5%FY 2017: 10.9%FY 2018: 20.8%FY 2019: 14.6%FY 2020: 10.5%FY 2021: 13.8%FY 2022: 14.4%FY 2023: 13.0%FY 2024: 11.8%FY 2025: 9.5%
FY 2016 5y median 13.0% FY 2025
ROIC 7.6%
FY 2016: 16.3%FY 2017: 9.7%FY 2018: 18.9%FY 2019: 13.7%FY 2020: 9.9%FY 2021: 13.1%FY 2022: 13.4%FY 2023: 10.6%FY 2024: 9.4%FY 2025: 7.6%
FY 2016 5y median 10.6% FY 2025
ROA 9.2%
FY 2016: 15.8%FY 2017: 9.2%FY 2018: 18.6%FY 2019: 13.4%FY 2020: 9.7%FY 2021: 12.8%FY 2022: 13.3%FY 2023: 12.3%FY 2024: 11.3%FY 2025: 9.2%
FY 2016 5y median 12.3% FY 2025

Growth (YoY)

Revenue -5.8%
FY 2016: -2.1%FY 2017: 5.4%FY 2018: 1.4%FY 2019: 11.7%FY 2020: -10.1%FY 2021: 16.3%FY 2022: 6.6%FY 2023: -3.9%FY 2024: -18.6%FY 2025: -5.8%
FY 2016 FY 2025
Operating Income -16.1%
FY 2016: 3.4%FY 2017: 17.4%FY 2018: -1.7%FY 2019: -5.7%FY 2020: -22.3%FY 2021: 37.7%FY 2022: 4.8%FY 2023: -15.2%FY 2024: -19.0%FY 2025: -16.1%
FY 2016 FY 2025
EPS (diluted) -12.1%
FY 2016: 2.5%FY 2017: -29.2%FY 2018: 117.1%FY 2019: -20.4%FY 2020: -25.4%FY 2021: 37.4%FY 2022: 11.9%FY 2023: 1.1%FY 2024: -13.3%FY 2025: -12.1%
FY 2016 FY 2025
Free Cash Flow -1.9%
FY 2016: -17.2%FY 2017: 36.4%FY 2018: 7.3%FY 2019: -127.3%FY 2020: 529.9%FY 2021: 7.1%FY 2022: -1.6%FY 2023: 6.5%FY 2024: -32.6%FY 2025: -1.9%
FY 2016 FY 2025

Financial Health

Current Ratio 37.6×
FY 2016: 11.5×FY 2017: 9.3×FY 2018: 11.6×FY 2019: 15.9×FY 2020: 16.4×FY 2021: 19.5×FY 2022: 15.1×FY 2023: 22.6×FY 2024: 25.6×FY 2025: 37.6×
FY 2016 5y median 22.6× FY 2025
Quick Ratio 34.6×
FY 2016: 10.0×FY 2017: 8.3×FY 2018: 10.5×FY 2019: 13.9×FY 2020: 14.8×FY 2021: 17.8×FY 2022: 13.6×FY 2023: 20.5×FY 2024: 23.3×FY 2025: 34.6×
FY 2016 5y median 20.5× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -5.0×
FY 2016: -1.4×FY 2017: -1.8×FY 2018: -2.4×FY 2019: -1.7×FY 2020: -2.5×FY 2021: -2.3×FY 2022: -2.7×FY 2023: -3.7×FY 2024: -4.2×FY 2025: -5.0×
FY 2016 5y median -3.7× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 2.2%
FY 2016: 1.4%FY 2017: 1.0%FY 2018: 1.3%FY 2019: 1.0%FY 2020: 1.3%FY 2021: 3.1%FY 2022: 0.9%FY 2023: 1.4%FY 2024: 2.0%FY 2025: 2.2%
FY 2016 5y median 2.0% FY 2025
Payout Ratio 35.3%
FY 2016: 32.3%FY 2017: 34.7%FY 2018: 21.7%FY 2019: 27.9%FY 2020: 38.1%FY 2021: 77.5%FY 2022: 19.2%FY 2023: 25.7%FY 2024: 30.7%FY 2025: 35.3%
FY 2016 5y median 30.7% FY 2025

Annual · latest fiscal year ends 2025-12-31